MedTrace Logo

Dexamethasone for Post Uterine Artery Embolization Pain

NCT04655144 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2026-01-07

Study results available
· View outcomes & findings →

Summary

The purpose of this research is to investigate if administration steroids (anti-inflammatory medication) via the uterine arteries during uterine fibroid embolization (A non surgical procedure for treating uterine fibroids by blocking their blood supply) can help reduce the pain, nausea, vomiting, and general feeling of weakness following the procedure.

Conditions

  • Leiomyoma

Interventions

DRUG

Dexamethasone

Dexamethasone delivered to the uterine arterial bed, prior to embolization.

DRUG

Saline

Saline delivered to the uterine arterial bed, prior to embolization.

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Prasoon Mohan, MD · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-25
Primary Completion
2024-12-04
Completion
2024-12-04
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04655144 on ClinicalTrials.gov